Bruker and 10x Genomics settle patent dispute

Ross Law

Wed, May 14, 2025, 10:32 AM 2 min read

Bruker and 10x Genomics person agreed to settee a patent quality relating to products primitively developed by Nanostring, a institution Bruker acquired successful 2024.

Under the settlement, whose fiscal presumption person not been disclosed, the 2 companies person entered into planetary cross-license agreements for their patents. Additionally, each ongoing lawsuits and administrative proceedings successful the US, Germany, and earlier the European Unified Patent Court, volition beryllium withdrawn.

Filed by 10x successful 2023, the archetypal suit asserted that Nanostring’s GeoMx Digital Spatial Profiler, a merchandise that profiles the spatial organisation of RNA and macromolecule look crossed a insubstantial sample, infringed connected 7 patents. In November 2023, the territory tribunal of Delaware sided with 10x.

Nanostring, a publically listed institution erstwhile the suit was filed, went bankrupt successful February 2024. Bruker acquired the institution a period aboriginal for $392.6m, and inherited the lawsuit.

On 23 December 2024, Delaware’s territory tribunal issued its ruling connected post-trial motions, successful which damages of $31.6m were upheld, yet enhanced damages requested by 10x were declined. The last motion, an injunction petition by 10x, was granted by the court, meaning that income of GeoMx products to caller customers successful the US would beryllium halted.

At the time, Todd Garland, Bruker spatial biology division’s president, said the institution would “promptly question a stay” connected immoderate injunction ordered and looked guardant to the entreaty of its lawsuit being heard by the US Court of Appeals for the Federal Circuit.

Commenting connected the colony agreement, Mark Munch, president of the Bruker Nano Group, said the institution was blessed to person the “distraction and expense” of the ineligible cases down it.

“We’re pleased that we person reached a worldwide colony with 10x, putting an extremity to each litigation betwixt us,” Munch said.

“This is simply a large result for the technological community, who tin proceed their enactment utilizing Bruker’s CosMx and GeoMx spatial biology platforms without interest that litigation could interfere with their advancements successful oncology, neurobiology, and different fields of research.”

"Bruker and 10x Genomics settee patent dispute" was primitively created and published by Medical Device Network, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.